Ghrelin level negatively predicts quality of life in obese women

References

• Agin, A., Jeandidier, N., Gasser, F., Grucker, D., & Sapin, R. (2006). Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment. Clinical Chemistry and Laboratory Medicine, 44, 1379–1382.
   PubMed Web of Science ®Google Scholar
• Bacha, F., & Arslanian, S. A. (2005). Ghrelin suppression in overweight children: A manifestation of insulin resistance? The Journal of Clinical Endocrinology & Metabolism, 90, 2725–2730.10.1210/jc.2004-1582
   PubMed Web of Science ®Google Scholar
• Barim, A. O., Aydin, S., Colak, R., Dag, E., Deniz, O., & Sahin, I. (2009). Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clinical Biochemistry, 42, 1076–1081.10.1016/j.clinbiochem.2009.02.020
   PubMed Web of Science ®Google Scholar
• Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 50, 1714–1719.10.2337/diabetes.50.8.1714
   PubMed Web of Science ®Google Scholar
• Damdindorj, B., Dezaki, K., Kurashina, T., Sone, H., Rita, R., Kakei, M., & Yada, T. (2012). Exogenous and endogenous ghrelin counteracts GLP-1 action to stimulate cAMP signaling and insulin secretion in islet beta-cells. FEBS Letters, 586, 2555–2562.10.1016/j.febslet.2012.06.034
   PubMed Web of Science ®Google Scholar
• Dixon, J. B. (2010). The effect of obesity on health outcomes. Molecular and Cellular Endocrinology, 316, 104–108.10.1016/j.mce.2009.07.008
   PubMed Web of Science ®Google Scholar
• Flier, J. S., & Maratos-Flier, E. (1998). Obesity and the hypothalamus: Novel peptides for new pathways. Cell, 92, 437–440.10.1016/S0092-8674(00)80937-X
   PubMed Web of Science ®Google Scholar
• Ford, E. S., & Li, C. (2008). Metabolic syndrome and health-related quality of life among U.S. adults. Annals of Epidemiology, 18, 165–171.10.1016/j.annepidem.2007.10.009
   PubMed Web of Science ®Google Scholar
• Gale, S. M., Castracane, V. D., & Mantzoros, C. S. (2004). Energy homeostasis, obesity and eating disorders: Recent advances in endocrinology. Journal of Nutrition, 134, 295–298.
   PubMed Web of Science ®Google Scholar
• Han, J. H., Park, H. S., Shin, C. I., Chang, H. M., Yun, K. E., Cho, S. H., … Bae, S. C. (2009). Metabolic syndrome and quality of life (QOL) using generalised and obesity-specific QOL scales. International Journal of Clinical Practice, 63, 735–741.10.1111/ijcp.2009.63.issue-5
   PubMed Web of Science ®Google Scholar
• Heo, M., Allison, D. B., Faith, M. S., Zhu, S., & Fontaine, K. R. (2003). Obesity and quality of life: Mediating effects of pain and comorbidities. Obesity Research, 11, 209–216.10.1038/oby.2003.33
   PubMedGoogle Scholar
• Jaskula, M., Wasko, R., Komarowska, H., Dziubandowska, A., & Sowinski, J. (2009). Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly. Neuro Endocrinology Letters, 30, 245–255.
   PubMed Web of Science ®Google Scholar
• Lutter, M., Sakata, I., Osborne-Lawrence, S., Rovinsky, S. A., Anderson, J. G., Jung, S., … Zigman, J. M. (2008). The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nature Neuroscience, 11, 752–753.10.1038/nn.2139
   PubMed Web of Science ®Google Scholar
• Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412–419.10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003). Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association, 289, 76–79.
   PubMed Web of Science ®Google Scholar
• Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., & Dietz, W. H. (1999). The disease burden associated with overweight and obesity. Journal of the American Medical Association, 282, 1523–1529.10.1001/jama.282.16.1523
   PubMed Web of Science ®Google Scholar
• Nogueira, J. P., Maraninchi, M., Beliard, S., Lorec, A. M., Berthet, B., Begu-Le Corroller, A., … Valero, R. (2012). Unacylated ghrelin is associated with the isolated low HDL-cholesterol obese phenotype independently of insulin resistance and CRP level. Nutrition & Metabolism, 9, 17.10.1186/1743-7075-9-17
   PubMed Web of Science ®Google Scholar
• Peyrot, M., Rubin, R. R., Chen, X., & Frias, J. P. (2011). Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus. Diabetes Technology & Therapeutics, 13, 471–476.10.1089/dia.2010.0167
   PubMed Web of Science ®Google Scholar
• Poykko, S. M., Kellokoski, E., Horkko, S., Kauma, H., Kesaniemi, Y. A., & Ukkola, O. (2003). Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 52, 2546–2553.10.2337/diabetes.52.10.2546
   PubMed Web of Science ®Google Scholar
• Pulkkinen, L., Ukkola, O., Kolehmainen, M., & Uusitupa, M. (2010). Ghrelin in diabetes and metabolic syndrome. International Journal of Peptides.
   PubMedGoogle Scholar
• Reuser, M., Bonneux, L. G., & Willekens, F. J. (2009). Smoking kills, obesity disables: A multistate approach of the US health and retirement survey. Obesity, 17, 783–789.10.1038/oby.2008.640
   PubMed Web of Science ®Google Scholar
• Schellekens, H., Finger, B. C., Dinan, T. G., & Cryan, J. F. (2012). Ghrelin signalling and obesity: At the interface of stress, mood and food reward. Pharmacology and Therapeutics, 135, 316–326.
   PubMed Web of Science ®Google Scholar
• Schofl, C., Horn, R., Schill, T., Schlosser, H. W., Muller, M. J., & Brabant, G. (2002). Circulating ghrelin levels in patients with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 87, 4607–4610.10.1210/jc.2002-020505
   PubMed Web of Science ®Google Scholar
• Schutte, A. E., Huisman, H. W., Schutte, R., van Rooyen, J. M., Malan, L., Fourie, C. M. T., & Malan, N. T. (2010). Adipokines and cardiometabolic function: How are they interlinked? Regulatory Peptides, 164, 133–138.10.1016/j.regpep.2010.06.008
   PubMedGoogle Scholar
• Schwimmer, J. B., Burwinkle, T. M., & Varni, J. W. (2003). Health-related quality of life of severely obese children and adolescents. Journal of the American Medical Association, 289, 1813–1819.10.1001/jama.289.14.1813
   PubMed Web of Science ®Google Scholar
• Sirtori, A., Brunani, A., Villa, V., Berselli, M. E., Croci, M., Leonardi, M., & Raggi, A. (2012). Obesity is a marker of reduction in QoL and disability. Scientific World Journal, 2012. doi:10.1100/2012/167520.
   Web of Science ®Google Scholar
• Starr, J. I., Mako, M. E., Juhn, D., & Rubenstein, A. H. (1978). Measurement of serum proinsulin-like material: Cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay. Journal of Laboratory and Clinical Medicine, 91, 683–692.
   PubMed Web of Science ®Google Scholar
• Tabak, O., Gelisgen, R., Cicekci, H., Senates, E., Erdenen, F., Muderrisoglu, C., … Uzun, H. (2012). Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome. Minerva Medica, 103, 323–329.
   PubMed Web of Science ®Google Scholar
• Tsai, A. G., Wadden, T. A., Sarwer, D. B., Berkowitz, R. I., Womble, L. G., Hesson, L. A., … Rothman, R. (2007). Metabolic syndrome and health-related quality of life in obese individuals seeking weight reduction. Obesity, 16, 59–63.
   Web of Science ®Google Scholar
• Tschop, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., & Heiman, M. L. (2001). Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707–709.10.2337/diabetes.50.4.707
   PubMed Web of Science ®Google Scholar
• Ukkola, O. (2009). Ghrelin and metabolic disorders. Current Protein & Peptide Science, 10, 2–7.10.2174/138920309787315220
   PubMed Web of Science ®Google Scholar
• Verhulst, P. J., & Depoortere, I. (2012). Ghrelin’s second life: From appetite stimulator to glucose regulator. World Journal of Gastroenterology, 18, 3183–3195.
   PubMed Web of Science ®Google Scholar
• Wardle, J., Chida, Y., Gibson, E. L., Whitaker, K. L., & Steptoe, A. (2011). Stress and adiposity: A meta-analysis of longitudinal studies. Obesity, 19, 771–778.10.1038/oby.2010.241
   PubMed Web of Science ®Google Scholar
• Ware, Jr. J., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.10.1097/00005650-199603000-00003
   PubMed Web of Science ®Google Scholar
• Yancy, Jr. W. S., Olsen, M. K., Westman, E. C., Bosworth, H. B., & Edelman, D. (2002). Relationship between obesity and health-related quality of life in men. Obesity Research, 10, 1057–1064.10.1038/oby.2002.143
   PubMedGoogle Scholar
• Yao, G., Chung, C. W., Yu, C. F., & Wang, J. D. (2002). Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. Journal of the Formosan Medical Association, 101, 342–351.
   PubMed Web of Science ®Google Scholar
• Zeller, M. H., & Modi, A. C. (2006). Predictors of health-related quality of life in obese youth. Obesity, 14, 122–130.10.1038/oby.2006.15
   PubMed Web of Science ®Google Scholar